Osteoporosis in patients with inflammatory bowel disease

Gut

Volumn 50, Issue 1, 2002, Pages 9-10

  Arden, N K ^a   Cooper, C ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; CORTICOSTEROID; VITAMIN D;

ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; FRACTURE; HUMAN; HYPOGONADISM; LIFESTYLE; MALABSORPTION; MALNUTRITION; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY;

COHORT STUDIES; GLUCOCORTICOIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; LIFE STYLE; OSTEOPOROSIS; RISK FACTORS;

EID: 0036136159     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.1.9     Document Type: Article

References (9)

1. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease
2. The incidence of fracture among patients with inflammatory bowel disease
3. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
4. Use of oral corticosteroids and risk of fractures
5. Evaluation of calcaneal ultrasound and DXA to assess the risk of corticosteroid induced osteoporosis: A cross sectional study
6. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation
7. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease
8. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
9. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures